Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-99.74	-122.48	46729.36
Graham Fair Price	243.72	0.49	0.14
PEG	-99.82	-0.03	14.69
Price/Book	-7.68	20.83	22.56
Price/Cash Flow	-72.51	182.85	665.21
Prices/Earnings	94.22	-34.63	-599.52
Price/Sales	96.10	36.12	18.42
Price/FCF	-72.51	182.85	665.21
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	278.88	-0.23	0.06
Operating Margin	11240.91	-0.26	< 0.005
ROA	-1606.22	-0.04	< 0.005
ROE	< 0.005	-0.15	-1498.55
ROIC	< 0.005	-0.07	3804.49
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.16	0.77	-79.19
Dividends QOQ	0.09	-0.28	214.91
EBIT QOQ	1.16	-47.41	3991.70
EPS QOQ	0.41	-12.79	3034.31
FCF QOQ	1.12	1.92	71.91
Revenue QOQ	0.35	-0.59	68.82
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2.04	3.85	88.92
Days Sales Outstanding (DSO)	154.39	249.67	61.71
Inventory Turnover	44.12	23.36	-47.07
Debt/Capitalization	0.56	0.55	-1.56
Quick Ratio	0.84	0.75	-11.24
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.31	0.27	-14.03
Cash	0.12	0.11	-10.15
Capex	-0.02	-0.01	41.39
Free Cash Flow	0.01	0.03	188.74
Revenue	0.38	0.15	-59.53
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.86	0.76	-10.90
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1749.90	-4.61	-99.74
Naive Interpretation	Member

06 - Financial Health · Bad

Rating